KOTAK MAHINDRA BANK LIMITED. ESOPs / SARs Disclosure (For FY 2015-16)



Similar documents
CIRCULAR. CIR/CFD/POLICY CELL/2/2015 June 16, Sub: Requirements specified under the SEBI (Share Based Employee Benefits) Regulations, 2014

Share-Based Payments. 1. Introduction. 2. Definitions

Share Based Payments CHAPTER 7

Accounting for ESOP. IPCC Paper 5: Advanced Accounting Chapter 4. CA. Shruthi BN, Bangalore

Ind AS 102 Share-based Payments

Chapter 19 Share Based Compensation and Earnings Per Share

NOTICE. 1. To consider, and if thought fit, to pass, with or without modification(s), the following resolution as a Special Resolution.

Review of SEBI (Employee Stock Option Scheme & Employee Stock Purchase Scheme) Guidelines, Recommendations of the ESOP Committee

48 Share-based compensation plans

Draft Guidelines on Employee Stock Option Plans/ Employee Stock Purchase Plans (ESOP/ ESPP)

Accounting 2. Lecture no 6. Prepared by: Jan Hájek

SECURITIES AND EXCHANGE BOARD OF INDIA (EMPLOYEE STOCK OPTION SCHEME AND EMPLOYEE STOCK PURCHASE SCHEME) GUIDELINES, 1999

How To Understand And Understand The Principles Of Ifrs 2

EMPLOYEE STOCK OPTION PLAN (ESOP) Therefore, ESOP is primarily a kind of incentive to hold the employees to the company s fold.

CONSOLIDATED FINANCIAL STATEMENTS

APPENDIX D: FASB STATEMENT NO. 123, ACCOUNTING FOR STOCK-BASED COMPENSATION

Guidance Note on Accounting for Employee Share-based Payments

SEBI (Share Based Employee Benefits) Regulations, 2014

AcuityAds Inc. Condensed Consolidated Interim Financial Statements. Three months ended March 31, 2014 and 2013 (Unaudited)

International Financial Reporting Standard 2

ESOP AND SWEAT EQUITY CONCEPT, REGULATORY FRAMEWORK, ACCOUNTING AND TAXATION

ACCOUNTING STANDARDS BOARD OCTOBER 1998 FRS 14 FINANCIAL REPORTING STANDARD EARNINGS ACCOUNTING STANDARDS BOARD

Quick Reference Guide toJapan's Financial Statements in 2014

CONSOLIDATED FINANCIAL STATEMENTS

The Fair Value Method of Measuring Compensation for Employee Stock Options: Basic Principles and Illustrative Examples May 2002

Khan Resources Inc. Interim Consolidated Balance Sheets (Expressed in United States dollars) (All dollar amounts are in thousands) (Unaudited)

BLACKHEATH RESOURCES INC. FINANCIAL STATEMENTS 31 DECEMBER 2011

QUINSAM CAPITAL CORPORATION INTERIM FINANCIAL STATEMENTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2015 (UNAUDITED AND EXPRESSED IN CANADIAN DOLLARS)

A practical guide to share-based payments. February 2011

Share-based Payment. HKFRS 2 Revised February 2010June Effective for annual periods beginning on or after 1 January 2005

TITAN MEDICAL INC. Unaudited Condensed Interim Financial Statements Three and Nine Months Ended September 30, 2014 and 2013 (IN UNITED STATES DOLLARS)

EIGHT SOLUTIONS INC.

Long Term Incentive Plan

Earnings Per Share. Contents. Accounting Standard (AS) 20

Stock Compensation. Bryan Palbaum Partner KPMG LLP A S S U R A N C E

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2013 AND 2012.

eqube Gaming Limited Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended November 30, 2015 (Unaudited)

Appendix B IMPLEMENTATION GUIDANCE

NUVISTA ENERGY LTD. Consolidated Statements of Financial Position (unaudited)

The McGraw-Hill Companies, Inc., 2013 Solutions Manual, Vol.2, Chapter

FRS 14 FINANCIAL REPORTING STANDARDS CONTENTS. Paragraph

1-3Q of FY Q of FY

Condensed Interim Consolidated Financial Statements Three months ended July 31, 2012 (Unaudited)

EMPLOYEES STOCK OPTION PLAN, 2000 (ESOP 2000)

TITAN MEDICAL INC. Unaudited Condensed Interim Financial Statements Three Months Ended March 31, 2016 and 2015 (IN UNITED STATES DOLLARS)

D1. This Statement supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees, and the following related interpretations of Opinion 25:

Equity Compensation Reporting:

Appendix 3B. Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS September 30, 2015 (Unaudited) TSX-V: ANF.

FINANCIAL STATEMENTS OF THE COMPANY COMPANY STATEMENT OF FINANCIAL POSITION

An exploration stage company. Condensed Interim Consolidated Financial Statements

ANTIBE THERAPEUTICS INC. CONSOLIDATED FINANCIAL STATEMENTS MARCH 31, 2013

Compiled Accounting Standard AASB 2. Share-based Payment

Pacific Ridge Exploration Ltd. (An Exploration Stage Company)

ENGINEERING.COM INCORPORATED 2002 FINANCIAL STATEMENTS

CONDENSED INTERIM. (Unaudited)

Interim Financial Statements. Opsens Inc. (after merger) Three-month period ended November 30, 2006

DETERMINING THE VALUE OF EMPLOYEE STOCK OPTIONS. Report Produced for the Ontario Teachers Pension Plan John Hull and Alan White August 2002

GENWORTH MI CANADA INC.

Notes to the Consolidated Financial Statements

CEMATRIX CORPORATION Consolidated Financial Statements (in Canadian dollars) September 30, 2015

AUNDE INDIA LIMITED POLICY FOR DETERMINATION OF MATERIALITY FOR DISCLOSURES

Notes on the parent company financial statements

ASPE AT A GLANCE Section 3870 Stock-based Compensation and Other Stock-based Payments

STAFF QUESTIONS AND ANSWERS

Accounting Standard (AS) 30 Financial Instruments: Recognition and Measurement

IFRS IN PRACTICE. Accounting for convertible notes

Accounting for Stock Compensation Under FASB ASC Topic 718

Symbility Solutions Inc. Interim Condensed Consolidated Financial Statements (Unaudited) Quarter ended June 30, 2015

DESIGNIT OSLO A/S STANDALONE FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED MARCH 31, 2016

CANADIAN GAAP IFRS COMPARISON SERIES

Expressed in Canadian Dollars - Unaudited

Heads Up (R)eady, Set, Go. December 17, 2004 Vol. 11, Issue 10. Fair Value Accounting for Stock Options! In This Issue:

ARROWSTAR RESOURCES LTD. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS SEPTEMBER 30, (Unaudited - Expressed in Canadian Dollars)

West Japan Railway Company

Disclosure of European Embedded Value as of March 31, 2015

FINANCIAL INFORMATION CONSOLIDATED FINANCIAL STATEMENTS. Risk management

Notes to the Financial Statements For the year ended 31 December 2010

SECURITIES & EXCHANGE COMMISSION EDGAR FILING COUNTERPATH CORP

FLOW TRADERS COÖPERATIEF U.A.

WESTFIELD REAL ESTATE INVESTMENT TRUST

SCORPEX INTERNATIONAL, INC.

CHAPTER 8 STOCK VALUATION

Introducing the potential for equity powered return with principal protection

FASB Technical Bulletin No. 97-1

WIPRO DOHA LLC FINANCIAL STATEMENTS AS AT AND FOR THE YEAR ENDED MARCH 31, 2016

International Tower Hill Mines Ltd.

Transcription:

KOTAK MAHINDRA BANK LIMITED ESOPs / SARs Disclosure (For FY 201516) [Pursuant to Regulation 14 of the SEBI (Share Based Employee Benefits) Regulations, 2014] The shareholders of the Bank at its Annual General Meeting held on 29 th June 2015 approved a new Scheme under the Securities and Exchange Board of India (Share Based Employee Benefits) Regulations, 2014, for the purposes of granting options and stock appreciation rights to the employees of the Bank, its subsidiaries and its associate companies, as applicable, viz. Kotak Mahindra Share Based Employee Benefit Scheme 2015 comprising of: Kotak Mahindra Equity Option Scheme 2015 and Kotak Mahindra Stock Appreciation Rights Scheme 2015 Further, pursuant to the Scheme of Amalgamation of ING Vysya Bank (IVBL) with the Bank, the ESOP Schemes of the erstwhile IVBL have been renamed and adopted by the Bank, as given below: Kotak Mahindra Bank Ltd. (IVBL) Employees Stock Option Scheme 2005, Kotak Mahindra Bank Ltd. (IVBL) Employees Stock Option Scheme 2007, Kotak Mahindra Bank Ltd. (IVBL) Employee Stock Option Scheme 2010, and Kotak Mahindra Bank Ltd. (IVBL) Employees Stock Option Scheme 2013 During the 201516, the following Schemes were in operation: Kotak Mahindra Equity Option Scheme 2007 ( KMBL ESOP Scheme 2007 ) Kotak Mahindra Equity Option Scheme 2015 ( KMBL ESOP Scheme 2015 ) Kotak Mahindra Bank Ltd. (IVBL) Employees Stock Option Scheme 2007 ( KMBL (IVBL) Scheme 2007 ) Kotak Mahindra Bank Ltd. (IVBL) Employee Stock Option Scheme 2010 ( KMBL (IVBL) Scheme 2010 ) Kotak Mahindra Bank Ltd. (IVBL) Employees Stock Option Scheme 2013 ( KMBL (IVBL) Scheme 2013 ) Kotak Mahindra Stock Appreciation Rights Scheme 2015 ( SARs Scheme 2015 ) A. Relevant disclosures in terms of the 'Guidance note on accounting for employee sharebased payments' issued by ICAI or any other relevant accounting standards as prescribed from time to time. Details provided in note 12 of Schedule 17 Notes to Accounts of the Consolidated financial statements and note 8 of Schedule 18C Notes to Accounts of the Standalone financial statements in the Bank s Annual Report 201516. B. Diluted EPS on issue of shares pursuant to all the schemes covered under the regulations shall be disclosed in accordance with 'Accounting Standard 20 Earnings Per Share' issued by ICAI or any other relevant accounting standards as prescribed from time to time. The diluted Earnings Per Share (EPS) pursuant to issue of shares on exercise of options calculated in accordance with AS20 is ` 18.87 (Consolidated) and `11.40 (Standalone)

C. Details related to Employee Stock Option (ESOP) Schemes ESOPs granted under KMBL Schemes Particulars KMBL ESOP Scheme 2007 KMBL ESOP Scheme 2015 (i) Description of each ESOP that existed at any time during the Date of shareholders approval Total number of options approved 5 th July 2007 as amended on 21 st August 2007 8,00,00,000 (postsplit & bonus adjusted number) 29 th June 2015 3,64,00,000 (post bonus adjusted number) Vesting requirements Graded / Cliff vesting Graded / Cliff vesting Exercise price or pricing Exercise Price shall be a price, as may be determined by the Board / formula ESOP / Compensation Committee, equivalent to or discounted up to 50% of the Average Market Price. The Average Market Price for this purpose would mean the average of the closing price of Equity Shares of the Bank, during two weeks period prior to the date of the meeting of Board/ESOP/Compensation Committee at which Plan Series under the Scheme is approved, on the Stock Exchange, where there was highest trading volume during the said two week period, on which the Equity Shares of the Bank are listed. Plan Series means a documented plan framed by Board / ESOP / Compensation Committee for each tranche of grant of Options, to all Eligible Employees, at a specific Exercise Price (which is determined by the Board / ESOP / Compensation Committee for the purpose of that particular Plan Series) and other terms and conditions as mentioned in that Plan Series. The Board / ESOP / Compensation Committee under special circumstances decides that the Exercise Price shall be ` 5 per share. In such cases, the immediately succeeding Directors Report / Corporate Governance Report shall carry details of the same. Exercise Price shall be a price, as may be determined by the Board/Compensation Committee, payable by the employee for exercising Options granted in pursuance of the Scheme, which will not be less than market price on the day prior to the Grant Date; In case of Wholetime Directors, the Exercise Price may be equivalent to or discounted up to 50% of the Average Market Price with a cap of 2,00,000 Options for each Wholetime Director in a financial. The Average Market Price would mean the average of the closing price of equity shares of the Bank during two weeks period prior to the date of the meeting of Board/Compensation Committee at which Plan Series under the ESOP Scheme 2015 is approved, on the Stock Exchange on which the equity shares of the Company are listed. In case the equity shares of the Company are listed on more than one Stock Exchange than the closing price at the Stock Exchange where there was highest trading volume during the said two week period shall be considered for determining the Average Market Price. Plan Series means a documented plan framed by the Board or the Compensation Committee for grant of Options at a specific Exercise Price in one or more tranches, which shall be determined by the Board or the Compensation Committee for the

Maximum term of options granted Source of shares (primary, secondary or combination) Variation in terms of options Vesting period upto 4.14 s from the Grant date. Exercise period upto 1.08 s from the Vesting date. Primary ii) Method used to account for ESOP Intrinsic or fair value Method used to account for ESOPs Intrinsic purpose of that particular Plan Series and as per the other terms and conditions as mentioned in that Plan Series. Vesting period upto 3.57 s from the Grant date. Exercise period upto 0.50 s from the Vesting date. Primary Intrinsic iii) Where the company opts for expensing of the options using the intrinsic value of options Where the company opts for expensing of the options using the intrinsic value of the options, the difference between the employee compensation cost so computed and the employee compensation cost that shall have been recognized if it had used the fair value of the options, shall be disclosed. The impact of this difference on profits and on EPS of the Company shall also be disclosed. Refer Note 1 iv) Option movement during the (For each ESOP) @ Number of Options 83,01,918 outstanding at the beginning of the period granted 38,01,400 14,000 during the 6,52,016 forfeited/ lapsed during the Number of Options vested 42,09,250 during the 27,08,204 exercised during the Number of shares arising as 27,08,204 a result of exercise of options Money realized by exercise `82,68,21,269.50/ of options (INR), if scheme is implemented directly by

the company Loan repaid by Trust during NA NA the from exercise price received 87,43,098 14,000 outstanding at the end of the 15,01,046 exercisable at the end of the v) Weightedaverage exercise prices and weighted average fair value of options Weighted average exercise prices and weighted average fair values of options shall be disclosed separately for options whose exercise price either equals or exceeds or is less than the market price of the stock. * The weighted average price of the stock options exercised is ` 305.30 and the weighted average fair value of the options granted is ` 184.86. vi) Employee wise details of options granted during the to @ (i) Senior management personnel Name No. of options granted (ii) Any other employee who receives a grant in any one of options amounting to 5% or more of options granted during that (iii) Identified employees who were granted option, during any one, equal to or exceeding 1% of the issued capital (excluding outstanding warrants and conversions) of the Company at the time of grant Series 48 Mr. Dipak Gupta (JMD) Exercise Price 75,400 `500 per share * The weighted average fair value of the options granted is `189.63. vii) A description of the method and significant assumptions used to estimate fair value of options A description of the method and significant assumptions used during the to estimate the fair values of A. Stock price It is the closing market price on the National Stock Exchange of India Limited prior to the meeting of the Board in which the options are granted. options, including the following weighted B. Volatility

average information: Volatility is a measure of the amount by which a price has fluctuated or is expected to fluctuate during a period. The measure of volatility used in the BlackScholes optionpricing model is the annualized standard deviation of the continuously compounded rates of return on the stock over a period of time. Accordingly, daily volatility of the Bank s stock price on the NSE for the period corresponding to the respective expected live of the different vesting, prior to the grant date has been considered. C. Risk free interest rate The riskfree interest rate being considered for the calculation is the interest rate applicable for maturity equal to the expected life of the options based on the zerocoupon yield curve for Government Securities as on the date of the respective grant. D. Time to Maturity/Expected Life of options The minimum life of a stock option is the vesting period and the maximum life is vesting period plus the exercise period. The Expected life of the options has been calculated as the average of the two extremes the minimum life and the maximum life. Since each vest has been considered as a separate grant, the expected life has been calculated for each vesting separately. E. Dividend yield The dividend yield for each grant has been derived by dividing the dividend per share by the market price per share. Weighted average information in respect of above assumptions has been provided in note 12 of Schedule 17 of the notes to accounts to the Consolidated financial statement in the Bank s Annual Report 201516. Weighted average information in respect of above assumptions has been provided in note 8 of Schedule 18C of the notes to accounts to the Standalone financial statement in the Bank s Annual Report 201516. @ Refer Note 2 ESOPs granted under KMBL (IVBL) Schemes Particulars KMBL (IVBL) Scheme 2007# @ KMBL (IVBL) Scheme 2010# @ KMBL (IVBL) Scheme 2013# @ Addition on amalgamation 12,45,010 57,73,046 46,42,198 Method of settlement (Cash/Equity) forfeited/ lapsed during the Number of Options vested during the exercised during the Number of shares arising as a result of exercise of options Money realized by exercise of options (INR), if scheme is implemented directly by the company Equity Equity Equity 2 536 12,45,010 57,73,046 46,42,198 8,37,324 43,80,058 33,59,526 8,37,324 43,80,058 33,59,526 ` 24,81,70,505/ ` 1,25,12,33,498/ ` 1,31,28,96,225/

outstanding at the end of the exercisable at the end of the Weighted average exercise prices and weighted average fair values of options shall be disclosed separately for options whose exercise price either equals or exceeds or is less than the market price of the stock. Method used to account for ESOPs Where the company opts for expensing of the options using the intrinsic value of the options, the difference between the employee compensation cost so computed and the employee compensation cost that shall have been recognized if it had used the fair value of the options, shall be disclosed. The impact of this difference on profits and on EPS of the Company shall also be disclosed. 4,07,684 13,92,986 12,82,136 4,07,684 13,92,986 12,82,136 * The weighted average price of the stock options exercised is `296.39 Intrinsic Refer Note 1 * The weighted average price of the stock options exercised is `285.67 * The weighted average price of the stock options exercised is `390.80 # Pursuant to the Scheme of Amalgamation of the erstwhile ING Vysya Bank Ltd. (eivbl) with the Bank, the entitlements to receive shares of eivbl under the former eivbl ESOP Schemes (now known as KMBL (IVBL) Schemes ) which were outstanding as on 1st April, 2015 have automatically become the entitlements to receive shares of the Bank, adjusted to reflect the swap ratio. The said KMBL (IVBL) Schemes were adopted and approved by the Board of Directors of the Bank at its meeting held on 3rd April, 2015. @ Refer Note 2 * Figures are derived by considering the options granted and exercised by employees of the Bank and its subsidiaries. E. Details related to Stock Appreciation Rights (SARs) The Bank and its subsidiaries under its various plans/series have granted 19,92,080 SARs during FY 2016. The SARs are settled in cash and vest on the respective due dates in a graded manner as per the terms and conditions of grant. The contractual life of the SARs outstanding range from 1.10 to 4.23 s. Particulars SARs outstanding at the beginning of the SARs under various plans/series @ 19,26,254 SARs granted during the 19,46,866 45,214 SARs under SARs Scheme 2015

SARs settled during the 14,98,960 SARs lapsed during the 2,06,020 SARs outstanding at the end of the 21,68,140 45,214 Out of the total 19,92,080 SARs granted during FY 2016, 45,214 SARs were granted under the SARs Scheme 2015 (duly approved by the shareholders) to the employees of the Bank and its subsidiaries. Details of SARs granted under SARs Scheme 2015 are as follows: Particulars SARs Scheme 2015 i) Description of each SAR scheme that existed at any time during the Date of shareholders approval 29th June 2015 Total number of shares approved under the SAR scheme 1,82,00,000 (post bonus adjusted number) Vesting requirements SARs shall vest any time after expiry of 1 from the date of grant as may be determined by the Compensation Committee SAR price or pricing formula Maximum term of SAR granted Method of settlement (whether in cash or equity) Choice of settlement (with the company or the employee or combination) Source of shares (primary, secondary or combination) SAR/Base Price shall be such price as may be determined by the Compensation Committee from time to time at which Plan Series under the Scheme is approved. The Compensation Committee shall formulate various Plan Series based on the recommendation of the management of the Company. Vesting Price means the Market Price as on the Vesting Date. Market Price means latest available closing price on a recognized stock exchange on which the shares of the Company are listed on the date immediately prior to the Vesting Date. If such shares are listed on more than one stock exchange having the highest trading volume shall be considered as the market price. Appreciation means the difference between the Vesting Price and the Base Price multiplied by the number of SARs granted. All SARs awarded shall vest in and be paid as Appreciation. Cash only Variation in terms of scheme ii) Method used to account for SAR Intrinsic or fair value Method used to account for SAR Intrinsic

iii) Where the company opts for expensing of SAR using the intrinsic value of SAR Where the company opts for expensing of SAR Refer Note 1 using the intrinsic value of SAR, the difference between the employee compensation cost so computed and the employee compensation cost that shall have been recognized if it had used the fair value of SAR, shall be disclosed. The impact of this difference on profits and on EPS of the company shall also be disclosed. iv) SAR movement during the Number of SARs outstanding at the beginning of the Number of SARs granted during the Series 1 14,920 Series 2 17,419 Series 3 12,875 Number of SARs forfeited / lapsed during the Number of SARs vested during the Number of SARs exercised / settled during the Number of SARs outstanding at the end of the 45,214 Number of SARs exercisable at the end of the v) Employee wise details of SARs granted during the to (i) Senior management personnel (ii) Any other employee who receives a grant in any one of amounting to 5% or more of SAR granted during that (iii) Identified employees who were granted SAR, during any one, equal to or exceeding 1% of the issued capital (excluding outstanding warrants and conversions) of the Company at the time of grant. Note 1: Note 2: Had the Bank (on Consolidated basis) recorded the compensation cost on the basis of Fair Valuation method instead of intrinsic value method, employee compensation cost would have been higher by ` 103.70 crore and the Consolidated profit after tax would have been lower by `67.81 crore. Consequently, the basic and diluted EPS of the Bank (Consolidated) would have been `18.54 and `18.50 respectively. Had the Bank (on Standalone basis) recorded the compensation cost computed on the basis of Fair Valuation method instead of intrinsic value method, employee compensation cost would have been higher by ` 93.52 crore and the Standalone profit after tax would have been lower by ` 61.16 crore. Consequently, the basic and diluted EPS of the Bank (Standalone) would have been `11.09 and `11.07 respectively. Figures are derived by considering the options granted and exercised by employees of the Bank and its subsidiaries. During the, the Bank had issued Bonus shares in the ratio of 1:1. Accordingly, all the numbers of stock options & SARs are adjusted for bonus.